Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10351
AGM Group Holdings
AGMH
$2.27M
| $141K | ﹤0.01% |
4,993
+3,869
| +344% | +$211K |
|
10352
CALL
Spok Holdings
SPOK
$229M
| $141K | ﹤0.01% |
9,500
-3,100
| -25% | -$46.8K |
|
10353
PUT
Schwab US TIPS ETF
SCHP
$16.2B
| $140K | ﹤0.01% |
5,400
-4,200
| -44% | -$109K |
|
|
RYZ
10354
CALL
Ryerson Holding Corp
RYZ
$1.5B
| $140K | ﹤0.01% |
7,200
+4,600
| +177% | +$119K |
|
10355
PUT
Allot
ALLT
$383M
| $140K | ﹤0.01% |
60,500
+22,600
| +60% | +$48.9K |
|
10356
PUT
N-able
NABL
$650M
| $140K | ﹤0.01% |
9,200
+3,500
| +61% | +$46.1K |
|
10357
CALL
National Vision
EYE
$1.53B
| $140K | ﹤0.01% |
10,700
+6,000
| +128% | +$98.2K |
|
10358
Bridger Aerospace Warrant
BAERW
$8.49M
| $140K | ﹤0.01% |
1,000,066
+66
| +0% | +$10 |
|
10359
Dakota Gold
DC
$835M
| $140K | ﹤0.01% |
+54,841
| New | +$146K |
|
|
CRESY
10360
CALL
Cresud
CRESY
$750M
| $140K | ﹤0.01% |
17,144
-12,000
| -41% | -$110K |
|
10361
CALL
Civeo
CVEO
$344M
| $140K | ﹤0.01% |
5,600
+2,500
| +81% | +$62.3K |
|
|
GBIO
10362
DELISTED
Generation Bio
GBIO
| $140K | ﹤0.01% |
4,948
-814
| -14% | -$26.5K |
|
10363
CALL
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.85B
| $139K | ﹤0.01% |
3,600
-1,000
| -22% | -$38.4K |
|
10364
CALL
Titan International
TWI
$445M
| $139K | ﹤0.01% |
18,800
-12,200
| -39% | -$116K |
|
|
ADAP
10365
DELISTED
Adaptimmune Therapeutics
ADAP
| $139K | ﹤0.01% |
142,891
-100,800
| -41% | -$111K |
|
10366
CALL
Fidelity Total Bond ETF
FBND
$27.3B
| $139K | ﹤0.01% |
3,100
+3,000
| +3,000% | +$134K |
|
10367
PUT
AtaiBeckley Inc
ATAI
$2.69B
| $139K | ﹤0.01% |
104,600
+71,600
| +217% | +$129K |
|
10368
PUT
Supernus Pharmaceuticals
SUPN
$2.81B
| $139K | ﹤0.01% |
5,200
-4,300
| -45% | -$125K |
|
10369
CALL
Yext
YEXT
$594M
| $139K | ﹤0.01% |
26,000
-8,100
| -24% | -$43.6K |
|
10370
PUT
Equitable Holdings
EQH
$14.5B
| $139K | ﹤0.01% |
3,400
-2,500
| -42% | -$97.9K |
|
10371
AC Immune
ACIU
$253M
| $139K | ﹤0.01% |
34,808
-25,924
| -43% | -$85.8K |
|
|
LUXE
10372
LuxExperience B.V.
LUXE
$1.05B
| $139K | ﹤0.01% |
27,220
-13,084
| -32% | -$60.1K |
|
10373
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $139K | ﹤0.01% |
3,205
-27,163
| -89% | -$1.17M |
|
10374
Natural Health Trends
NHTC
$15.5M
| $139K | ﹤0.01% |
19,532
+1,976
| +11% | +$13.5K |
|
10375
CALL
Zai Lab
ZLAB
$2.91B
| $139K | ﹤0.01% |
8,000
-10,200
| -56% | -$179K |
|
Similar funds
Citadel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Citadel Advisors held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citadel Advisors withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Carrier Global worth $140M.
- Citadel Advisors's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Citadel Advisors added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Citadel Advisors's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Citadel Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Citadel Advisors's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Citadel Advisors opened 1,435 new positions and closed 1,760 in Q2 2024.
- Citadel Advisors's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.